Indonesia Covid-19 Expert Team Lead Wiku Adisasmito said the government will conduct a second phase of clinical trials on coronavirus vaccine research in August. This vaccine study is the result of cooperation between Indonesia and the South Korean government.
“We have confirmed that our research collaboration with Korea has received approval for clinical trials. Phase one will begin this month in Korea and Indonesia will take part in the second phase in August” Wiku said at a press conference on Thursday (18/6).
The clinical trial, said Wiku, will test whether the vaccine is able to counteract local transmissions of Covid-19. He asserted in this vaccine research, all parties worked together with a focus on patient safety.
Meanwhile, vaccine research conducted by Bio Farma and a biotechnology company from China, Sinovac Biotech Ltd., have passed the first phase of clinical trials. Wiku said that the second phase of immunology testing was currently underway.
“The results are likely to be announced at the end of June. The third phase of the plan is scheduled for July” he said.
Bio Farma and Sinovac vaccine production is targeted to begin immediately in late 2020.
The Indonesian government through PT Kalbe Farma Tbk is working closely with South Korean drug company Genexine Inc. to develop a new Covid-19 vaccine.
Vaccine research itself has been carried out on primates and has been proven to have produced antibodies capable of neutralizing new coronaviruses. The next stage will be tested on humans.